These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 22968722)
1. Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies. Hutton B; Joseph L; Fergusson D; Mazer CD; Shapiro S; Tinmouth A BMJ; 2012 Sep; 345():e5798. PubMed ID: 22968722 [TBL] [Abstract][Full Text] [Related]
2. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. Henry D; Carless P; Fergusson D; Laupacis A CMAJ; 2009 Jan; 180(2):183-93. PubMed ID: 19050037 [TBL] [Abstract][Full Text] [Related]
3. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD001886. PubMed ID: 21412876 [TBL] [Abstract][Full Text] [Related]
4. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K Cochrane Database Syst Rev; 2011 Jan; (1):CD001886. PubMed ID: 21249650 [TBL] [Abstract][Full Text] [Related]
5. The risk associated with aprotinin in cardiac surgery. Mangano DT; Tudor IC; Dietzel C; ; N Engl J Med; 2006 Jan; 354(4):353-65. PubMed ID: 16436767 [TBL] [Abstract][Full Text] [Related]
6. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; McClelland B; Laupacis A; Fergusson D Cochrane Database Syst Rev; 2007 Oct; (4):CD001886. PubMed ID: 17943760 [TBL] [Abstract][Full Text] [Related]
7. Antifibrinolytic drugs for acute traumatic injury. Ker K; Roberts I; Shakur H; Coats TJ Cochrane Database Syst Rev; 2015 May; 2015(5):CD004896. PubMed ID: 25956410 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of aprotinin in paediatric cardiac surgery: A systematic review and meta-analysis. Atasever AG; Eerens M; Van den Eynde R; Faraoni D; Rex S Eur J Anaesthesiol; 2022 Apr; 39(4):352-367. PubMed ID: 34783684 [TBL] [Abstract][Full Text] [Related]
9. Is epsilon-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery?: a meta-analysis. Munoz JJ; Birkmeyer NJ; Birkmeyer JD; O'Connor GT; Dacey LJ Circulation; 1999 Jan 5-12; 99(1):81-9. PubMed ID: 9884383 [TBL] [Abstract][Full Text] [Related]
10. Aprotinin may increase mortality in low and intermediate risk but not in high risk cardiac surgical patients compared to tranexamic acid and ε-aminocaproic acid -- a meta-analysis of randomised and observational trials of over 30.000 patients. Meybohm P; Herrmann E; Nierhoff J; Zacharowski K PLoS One; 2013; 8(3):e58009. PubMed ID: 23483965 [TBL] [Abstract][Full Text] [Related]
11. Antifibrinolytics in major orthopaedic surgery. Eubanks JD J Am Acad Orthop Surg; 2010 Mar; 18(3):132-8. PubMed ID: 20190103 [TBL] [Abstract][Full Text] [Related]
12. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions. van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192 [TBL] [Abstract][Full Text] [Related]
13. Methods to decrease blood loss and transfusion requirements for liver transplantation. Gurusamy KS; Pissanou T; Pikhart H; Vaughan J; Burroughs AK; Davidson BR Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD009052. PubMed ID: 22161443 [TBL] [Abstract][Full Text] [Related]
14. Putting the record straight on aprotinin as safe and effective: results from a mixed treatment meta-analysis of trials of aprotinin. Howell N; Senanayake E; Freemantle N; Pagano D J Thorac Cardiovasc Surg; 2013 Jan; 145(1):234-40. PubMed ID: 22889481 [TBL] [Abstract][Full Text] [Related]
16. Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis. Sander M; Spies CD; Martiny V; Rosenthal C; Wernecke KD; von Heymann C Crit Care; 2010; 14(4):R148. PubMed ID: 20682059 [TBL] [Abstract][Full Text] [Related]
17. Aprotinin increases mortality as compared with tranexamic acid in cardiac surgery: a meta-analysis of randomized head-to-head trials. Takagi H; Manabe H; Kawai N; Goto SN; Umemoto T Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):98-101. PubMed ID: 19380335 [TBL] [Abstract][Full Text] [Related]
18. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial. Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838 [TBL] [Abstract][Full Text] [Related]
19. Antifibrinolytic Drugs for the Prevention of Bleeding in Pediatric Cardiac Surgery on Cardiopulmonary Bypass: A Systematic Review and Meta-analysis. Siemens K; Sangaran DP; Hunt BJ; Murdoch IA; Tibby SM Anesth Analg; 2022 May; 134(5):987-1001. PubMed ID: 34633994 [TBL] [Abstract][Full Text] [Related]
20. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Laupacis A; Fergusson D Anesth Analg; 1997 Dec; 85(6):1258-67. PubMed ID: 9390590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]